Natalja Rashidovna Varina

Natalja Rashidovna Varina

Auto-generated profile, based on publicly available information

Natalja Rashidovna Varina

Samara State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2024 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
VKV. A. Kurkin
V. A. Kurkin
NVN. R. Varina
N. R. Varina
EAElena Avdeeva
Elena Avdeeva
IRI. V. Ruzaeva
I. V. Ruzaeva
 The aimof the work wasto analyze the current research state of phenylpropanoids as a special specific class of biologically active compounds and the prospects for their use for the development of medicines and biologically active food additives.Materials and methods.The scientific data for the period from 1968 to 2023 were studied in the databases of Scopus, ScienceDirect, PubMed, Google Scholar, e-library.ru, ResearchGate – a scientific information network. Herewith, the following keywords were used: “phenylpropanoids”, “antioxidants”, “hepatoprotectors”, “immunomodulators”, “organoprotectors”, “anxiolytics”, “adaptogens”, “preventive medicine”, “sanogenesis”, “medicines”, “biologically active food additives”, “sports medicine” and their English-language analogues.Results.This scientific research examines the main stages and results of studying the class of phenylpropanoids in the following aspects: a chemical structure and classification, biosynthesis and its role in the biogenesis of other classes of phenolic compounds, their distribution, biological and pharmacological activity in the plant world, the search for plant sources and their use in medicine and pharmacy. The existing and potential applications of phenylpropanoids for preventive and therapeutic purposes are discussed.Conclusion.The analysis of the scientific publications on the pharmacognostic and biomedical studies of the medicinal plants containing phenylpropanoids, substantiates the expediency of considering them as an autonomous specific class of biologically active compounds. The organoprotective profile of their action and a wide range of specific pharmacological activities of phenylpropanoids are connected by common links of the sanogenesis in the “prooxidant–antioxidant” system. The choosing of promising plant sources for the development of medicines and biologically active compounds with specified properties is justified from the dependence position of “chemical composition – structure of compounds – spectrum of activity”.

30 June 2021 in Science and Innovations in Medicine
Verified
Journal Article
Open access
PDF file
VKVladimir A. Kurkin
Vladimir A. Kurkin
EAElena Avdeeva
Elena Avdeeva
OPOlga E. Pravdivtseva
Olga E. Pravdivtseva
AKAnna V. Kurkinа
Anna V. Kurkinа
NVNatalya R. Varina
Natalya R. Varina
ЦСЦибина Анастасия Сергеевна
Цибина Анастасия Сергеевна
Objectives to provide scientific evidence for rational use of herbal medicines in otorhinolaryngological practice. Material and methods. The study included the following plants: Eucalyptus viminalis leaves, Monarda fistulosa herbs, Melissa officinalis herbs, Echinacea purpurea herbs, Calendula officinalis flowers, rhizomes of Rhodiola rosea, rhizomes of Eleutherococcus senticosus, Glycyrrhiza glabra roots, Macleaya microcarpa herbs, Macleaya cordata herbs, Plantago major leaves, Origanum vulgare herbs, Thymus serpyllum herbs. Phenylpropanoids, flavonoids, euglobals, monoterpene phenols, phenylpropanoids, terpenoids of essential oils, saponins and alkaloids were isolated from the medicinal plants and studied with thin-layer chromatography, spectrophotometry, NMR spectroscopy, mass spectrometry, and various chemical transformations. Results. It was scientifically proved that medicinal plants containing such biologically active compounds as phenylpropanoids, flavonoids, euglobals, terpenoid and phenolic components of essential oils, saponins, carotenoids, alkaloids and polysaccharides are useful for otorhinolaryngology. The active substances of the mentioned chemical groups in combination can provide antimicrobial, antifungal, antiviral, anti-inflammatory, regenerating, antihistamine, adaptogenic and immunomodulatory effects. Conclusion. The expediency of using medicinal herbal preparations containing euglobals, monoterpene phenols, flavonoids, phenylpropanoids, terpenoids of essential oils, saponins, alkaloids and polysaccharides in otorhinolaryngological practice was scientifically justified.

1 January 2021 in Farmaciya (Pharmacy)
Verified
Journal Article
Closed access
NVNadezhda Alexandrovna Volkova
Nadezhda Alexandrovna Volkova
VKVladimir Alexandrovich Kurkin
Vladimir Alexandrovich Kurkin
OPOlga Evgenevna Pravdivtseva
Olga Evgenevna Pravdivtseva
AKAnna Vladimirovna Kurkina
Anna Vladimirovna Kurkina
NVNatalja Rashidovna Varina
Natalja Rashidovna Varina
OSOlga Vladimirovna Sharova
Olga Vladimirovna Sharova

19 December 2025 in Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
EAElena Avdeeva
Elena Avdeeva
NVN. R. Varina
N. R. Varina
TRTatyana K. Ryazanova
Tatyana K. Ryazanova
VKV. A. Kurkin
V. A. Kurkin
NIN. V. Isakova
N. V. Isakova
DPD. A. Poltoretskii
D. A. Poltoretskii
INTRODUCTION. A holistic understanding of the physiological and biochemical pathways involved in pathogenesis is needed both for doctors diagnosing and treating patients and for drug developers. The accumulated knowledge in medicine and related fields, combined with the rapid development of digital tools, enables simulating the response systems of the body under normal and pathological conditions at a qualitatively new level. Being able to perform such simulations will lead to creating a digital architecture of body conditions, with interconnected links in the chain of pathogenesis being the focal points for researchers advancing medicines from early development to clinical trials. AIM. This study aimed to review the existing approaches that could form a foundation for constructing an aetiopathogenetic architecture of pathological conditions and diseases that would serve as a framework for targeted drug development. DISCUSSION. Using gout as a case study, the authors demonstrated the necessity and possibility of developing a three-dimensional aetiopathogenetic architecture of pathological conditions and diseases that would be based on the hierarchical relationships of pathological processes at different biological organisation levels. The study identified key applications for the aetiopathogenetic architecture. In medicine, the aetiopathogenetic architecture could be used in data-driven individual diagnostics and personalised pharmacotherapy. In pharmaceutics, the aetiopathogenetic architecture could provide a platform for investigating pharmacodynamics, from screening candidate compounds to applying targeted and multitargeted approaches in pharmaceutical development. The authors used the aetiopathogenetic architecture of gout as a case study to discuss the logic behind designing studies of medicines. CONCLUSIONS. The article proposes a methodology for constructing an aetiopathogenetic architecture reflecting cause-and-effect relationships of different significance to the development of pathological conditions and diseases. The aetiopathogenetic approach should become an integrative framework for all stages of the development and use of novel medicines, as well as a basis for expanding the indications for existing medicines. New opportunities are arising for the development of aetiopathogenetic models of varying complexity that can be used in projects ranging from drug design at the molecular level to pathophysiological modelling at the organismal level.

1 January 2022 in Традиционная медицина
Verified
Journal Article
Closed access
VKV.A. Kurkin
V.A. Kurkin
NVN.A. Volkova
N.A. Volkova
OPO.E. Pravdivtseva
O.E. Pravdivtseva
PTP.V. Trifonova
P.V. Trifonova
NVN.R. Varina
N.R. Varina
AAA.I. Agapov
A.I. Agapov
Лекарственные средства на основе сырья боярышника (Crataegus L.) широко используются как в Российской Федерации, так и за рубежом. В нашей стране используются плоды и цветки боярышника, а за рубежом применяются плоды, цветки с листьями. На основе побегов Crataegus sanguinea Pall., Crataegus monogina Jacq. и Crataegus submollis Sarg. были получены густые экстракты с высоким содержанием суммы флавоноидов. Для густых экстрактов боярышника однопестичного и боярышника кроваво-красного характерный максимум дифференциальных кривых поглощения составляет 392 нм, что соответствует 2II-О-рамнозид витексину. При этом у боярышника мягковатого этот показатель составляет 412 нм, что типично для гиперозида. Побеги боярышника являются перспективным видом лекарственного растительного сырья и могут служить в качестве источника получения препаратов, в том числе густого экстракта. Боярышник мягковатый является перспективным лекарственным...

31 March 2024 in Традиционная медицина
Verified
Journal Article
Closed access
PDF file
ВКВладимир Александрович Куркин
Владимир Александрович Куркин
АААркадий Алексеевич Андреев
Аркадий Алексеевич Андреев
ЮАЮлия Андреевна Андреева
Юлия Андреевна Андреева
ОПОльга Евгеньевна Правдивцева
Ольга Евгеньевна Правдивцева
НВНаталья Рашидовна Варина
Наталья Рашидовна Варина
ВСВиктория Викторовна Стеняева
Виктория Викторовна Стеняева
Сочные плоды аронии черноплодной (Aronia melanocarpa Elliot.), а также боярышника мягковатого (Crataegus submollis Sarg.) и боярышника вееровидного [Crataegus flabellatа (Bosc ex Spach) K. Koch.)] могут быть использованы для получения соков. Соки плодов лекарственных растений могут применяться в медицинской практике Российской Федерации в качестве лекарственных препаратов. Замораживание является эффективным способом хранения для сочных плодов. Целью нашей работы является сравнительный анализ получения соков из свежесобранных и замороженных плодов аронии черноплодной, боярышника мягковатого и боярышника вееровидного. Показано, что при использовании размороженных плодов сок получается в большем объеме и отличается более высоким содержанием суммы флавоноидов. The juicy fruits of Aronia melanocarpa Elliot., as well as Crataegus submollis Sarg. and Crataegus flabellata (Bosc ex Spach) K. Koch.) can be used to produce juices. The juices of the fruits of medicinal plants can be successfully used in the medical practice of the Russian Federation as medicines. Freezing is an effective storage method for juicy fruits. The purpose of our work is a comparative analysis of the production of juices from freshly harvested and frozen fruits of Aronia melanocarpa Elliot., Crataegus submollis Sarg. and Crataegus flabellata (Bosc ex Spach) K. Koch.). It was shown that when using thawed fruits, the juice is obtained in a larger volume and has a higher content of flavonoids.